Predictive Implications of KRAS and EGFR Gene Mutations in Non-small Cell Lung Cancer Treated with Radiation Therapy

被引：0
|
作者：
Likhacheva, A. [1 ]
Thomas, J. [1 ]
Kim, E. [1 ]
Allen, P. K. [1 ]
Komaki, R. [1 ]
Cox, J. [1 ]
Herbst, R. [1 ]
Welsh, J. [1 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [21] CAN MUTATIONS OF EGFR AND KRAS OF SERUM BE PREDICTIVE AND PROGNOSTIC MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)?
    Kim, S. T.
    Kim, Y. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S66 - S66
  • [22] PREDICTIVE VALUE OF KRAS AND BRAF MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH CHEMOTHERAPY
    Dingemans, Anne-Marie
    Smit, Egbert F.
    Heideman, Danielle
    Mellema, Wouter
    Derks, Jules
    Van, Robertjan Suylen
    Thunnissen, Erik
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1044 - S1044
  • [23] Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Heideman, Danielle A. M.
    van Suylen, Robertjan
    Thunnissen, Frederik B.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [24] EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Serdjebi, Cindy
    Khobta, Nataliya
    Metellus, Philippe
    Ouafik, L'Houcine
    Nanni, Isabelle
    Greillier, Laurent
    Loundou, Anderson
    Fina, Frederic
    Mascaux, Celine
    Barlesi, Fabrice
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)
  • [25] EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients
    Bae, Nack Cheon
    Chae, Myung Hwa
    Lee, Myung Hoon
    Kim, Kyung Mee
    Lee, Eung Bae
    Kim, Chang Ho
    Park, Tae-In
    Han, Sung Beom
    Jheon, Sanghoon
    Jung, Tae Hoon
    Park, Jae Yong
    CANCER GENETICS AND CYTOGENETICS, 2007, 173 (02) : 107 - 113
  • [26] Spectrum of EGFR gene mutations in Vietnamese patients with non-small cell lung cancer
    Hoang Anh Vu
    Phan Thi Xinh
    Hua Thi Ngoc Ha
    Ngo Thi Tuyet Hanh
    Nguyen Duc Bach
    Doan Thi Phuong Thao
    Ngo Quoc Dat
    Nguyen Sao Trung
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : 86 - 90
  • [27] THE FREQUENCY OF EGFR AND KRAS MUTATIONS IN NON-SMALL CELL LUNG CARCINOMAS IN THE DUTCH POPULATION
    Smits, Alexander J. J.
    Kummer, J. A.
    Hinrichs, John
    Herder, Gerarda J. M.
    Jiwa, N. M.
    Ruijters, T. E. G.
    Nooijen, P. T. G. A.
    Looijen-salamon, Monika G.
    Ligtenberg, M. J.
    Thunnissen, Frederik B.
    Heideman, Danielle A.
    De Weger, R. A.
    Vink, Aryan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1528 - S1528
  • [28] Predictive value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with chemotherapy (CT)
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Mellema, Wouter
    Heideman, Danielle
    Van Suylen, Robertjan
    Thunnissen, Erik
    CANCER RESEARCH, 2011, 71
  • [29] KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy
    Danenberg, K. D.
    Grimminger, P. P.
    Mack, P. C.
    Danenberg, P. V.
    Cooc, J.
    Stephens, C.
    Reddy, S. K.
    Li, T.
    Gandara, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
    Tang, Wenjie
    Li, Xiaolin
    Xi, Xueqi
    Sun, Xindong
    Liu, Jie
    Zhang, Jian
    Wang, Chungang
    Yu, Jinming
    Xie, Peng
    LUNG CANCER, 2019, 136 : 6 - 14
12345